Medical Researches
Possibly Effective
Based on 51 Researches
CECT 7347 reduces IBS-D symptomsA randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live CECT 7347 (ES1) and heat-treated CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome.
Highly relevant clinical findings
A randomized, double-blind, placebo-controlled trial exploring CECT 7347 (ES1) and heat-treated CECT 7347 (HT-ES1) revealed promising results for diarrhea-predominant irritable bowel syndrome (IBS-D).
We found that after 12 weeks, both ES1 and HT-ES1 significantly reduced symptom severity compared to a placebo, as shown by lower IBS-Symptom Severity Scale scores.
Other improvements included better stool consistency and quality of life. This study marks a breakthrough with the first positive findings for a probiotic or postbiotic from this strain specifically for IBS-D patients.
Read More
Effective treatment for IBS-CEffect of Lacticaseibacillus rhamnosus IDCC 3201 on irritable bowel syndrome with constipation: a randomized, double-blind, and placebo-controlled trial.
High relevance to IBS research
We aimed to understand how Lacticaseibacillus rhamnosus IDCC 3201 (RH 3201) affects irritable bowel syndrome with constipation (IBS-C) through a thorough study. In a randomized, double-blind trial, 30 participants took either RH 3201 or a placebo for 8 weeks.
Those taking RH 3201 experienced significant improvements, including fewer bowel discomforts and reduced bloating issues. We also observed an increase in certain beneficial gut bacteria and a link between specific metabolites and symptom relief. Overall, RH 3201 shows promise as an effective treatment for IBS-C.
Read More
Lactobacillus rhamnosus improves IBS symptoms[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
High relevance: significant findings
We explored how Lactobacillus rhamnosus, part of a complex probiotic called Neobiotic Lactobalance®, impacts patients with irritable bowel syndrome (IBS) with diarrhea and antibiotic-associated diarrhea (AAD).
In a 21-day study involving 54 patients, significant improvements were noted. Diarrheal symptoms in IBS patients dropped markedly from 17 to 6 points, while AAD symptoms fell from 13 to just 3 points.
Overall, we saw that this probiotic not only normalized gut bacteria but also substantially eased symptoms, suggesting it can be a valuable part of managing these digestive disorders.
Read More
Probiotics show promise for IBSEffects of Bifidobacterium longum BB536 and Lactobacillus rhamnosus HN001 in IBS patients.
Study score indicates notable findings.
We investigated the effects of a new formulation containing Lactobacillus rhamnosus and Bifidobacterium longum, supplemented with vitamin B6, on patients with irritable bowel syndrome (IBS). In a well-structured, double-blind, controlled trial with 25 participants, we found significant improvements in symptoms like abdominal pain and bloating compared to placebo.
Specifically, abdominal pain decreased by nearly 49% and bloating by over 36%. Additionally, we observed enhancements in intestinal permeability and an increase in beneficial gut bacteria.
Overall, this promising treatment highlights the potential of using probiotics to manage IBS symptoms effectively.
Read More
Bifidobacterium longum improves IBS symptoms[Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
Relevant findings on gut health
We evaluated how effective the probiotic Neobiotic Lactobalance®, which contains Bifidobacterium longum, is in treating symptoms of irritable bowel syndrome (IBS) with diarrhea and antibiotic-associated diarrhea (AAD).
In our study, 54 participants took one capsule daily for 21 days. We measured changes in symptom severity using a validated questionnaire and observed a significant reduction in symptoms for both IBS and AAD patients.
The microbiological analysis also showed improvement in gut bacteria, confirming that this probiotic can help restore intestinal balance.
Read More
User Reviews
Jarow Formulas has been instrumental in my health, containing eight essential intestinal bacteria. Thanks to this product, I no longer suffer from irritable bowel syndrome. I'm truly grateful.
I had various bowel problems before but now they've vanished completely. These probiotics have been incredibly effective, and I'm thoroughly satisfied with the outcome.
This probiotic is remarkable! It restored my bowel function after prolonged antibiotic use. I can confidently say it alleviated my irritable bowel syndrome symptoms, making my daily life much more comfortable.
Jarrow Lactobacillus is the best! For five years, I have noticed a dramatic difference in my bowel movements when I take it regularly. I ensure I consume it for my intestinal health; there’s nothing quite like it!
Live unconditionally! I've noticed a significant improvement in my immune system, especially with my irritable bowel syndrome. Consuming yogurt daily and two eggs has made a tremendous difference alongside taking this product weekly. A family member had a heavy condition but improved dramatically within a week. I've seen excellent effects and have even gifted it to friends, who reported positive outcomes too. I truly trust this product for its effectiveness and lack of side effects.
Read More